xavGE

xavGE xavGE

gouvernancefin
from gouvernancefin More from this publisher
28.10.2014 Views

Managing risk inadequately protects them. Outlined below are some specific circumstances where an individual officer or director may expect such protection. Derivative suit judgments or settlements: The ability of the company to indemnify its officers and directors for judgments or settlements resulting from a shareholder derivative action may be significantly limited or prohibited by statute in a company’s state of incorporation. For example, Delaware generally does not allow indemnification of settlements or judgments in an action brought by or on behalf of the company unless the court permits such action. In such circumstances, Side A coverage may apply as long as the conduct of individual directors and officers also complies with the limitations and exclusions of the insurance policy. Public policy prohibition against indemnification: Indemnification for claims related to registration of securities and antifraud provisions of the federal securities laws (and other federal statutes, such as the Racketeer Influenced and Corrupt Organizations Act and antitrust laws) may be precluded by public policy. The SEC’s view is that such indemnification is against public policy because it undermines the securities laws’ deterrent effect. However, the SEC does not regard the maintenance of D&O insurance as against public policy, even where the company pays the premium. As a result, it may be possible for insurance to respond to protect individual directors and officers in such circumstances where indemnification from the company is prohibited as a matter of public policy. Conduct not in “good faith” and “reasonable belief”: The company may indemnify a director or officer only if such person acted in good faith and in a manner that he or she reasonably believed to be in, or not opposed to, the best interests of the company. As a result, acts that do not satisfy the “good faith” and “reasonable belief” standard may not be indemnified by the company. In such circumstances, claims made against an individual director or officer may be insurable so long as the conduct of such individual also complies with the limitations and exclusions of the insurance policy. Refusal by board to indemnify: If the board or other authorized designee either declines in writing to indemnify an individual or fails to make or initiate a determination to indemnify an individual, insurance may respond to protect individual directors and officers, but it may be subject to a retention or deductible depending on the structure of the program. To avoid a circumstance where an individual insured might be personally responsible to pay a retention, many public companies today purchase a variation of Side A insurance often referred to as Side A DIC (the “DIC” refers to the “difference in conditions” provisions that are contained in this type of insurance policy). Side A DIC insurance provides broader coverage and is often purchased in addition to and in excess of the traditional D&O (Sides A, B and C) insurance described above. In a circumstance where the board or other authorized designee declines to indemnify an individual as described above, Side A DIC insurance could be called upon to provide directors and officers coverage at the primary level of the program (no retention). Near insolvency: Should the company approach insolvency, it will approach the “zone of insolvency,” where officers and directors may be deemed to owe certain fiduciary duties to creditors of the company. Although not yet insolvent, the company might choose not to indemnify a particular director or officer for fear that such act may be a breach of fiduciary duty owed to creditors of the company or may be the subject of an order by a bankruptcy trustee to return those proceeds. Insurance may respond if limits of the policy are not otherwise eroded. Actual insolvency or bankruptcy: The company either may be insolvent or, in the context of U.S. bankruptcy laws, may be unable or unwilling to indemnify an officer or director if the bankruptcy trustee determines that such indemnification is either unwarranted or improper. Moreover, assuming that such indemnification of an officer or director was warranted and proper, the proceeds of the policy might be deemed an asset of the “estate” and subject to an automatic stay. The obligation to indemnify may be deemed an unsecured obligation, placing the affected officer’s or director’s interest behind the interests of secured creditors and on par with other unsecured creditors awaiting payment or settlement. If there is some risk that the company may avail itself of the protection of U.S. bankruptcy laws, it may be useful to seek an explanation from the company’s insurance advisor and counsel as to how the company’s D&O insurance policy may respond to a number of potential issues. Key issues to understand would include identifying any issues related to: • how limits in the policy are either allocated or prioritized to coverage other than coverage of claims made against a director’s or officer’s personal assets; • whether the design of the company’s D&O insurance program is such that directors or officers will not be subject to a retention or deductible if the company is permitted to but fails to indemnify such an individual; and • what—if any—language exists in the policy to waive an automatic stay as regards the company’s policy. Choosing a D&O policy structure, limits, retention and insurers: The company should consider several questions before selecting the limits and structure of its D&O policy, including the following: • How susceptible is the company to a class action lawsuit or government enforcement action? • If the company suffers a class action lawsuit, what might it cost to defend and settle? • What limits, structures and retentions do the company’s peers purchase? • How can the balance between coverage, limit, retention and price be optimized? • What is the overall financial stability of each insurer on the program? • How can the program most costeffectively address exposure for foreign directors and officers? 92 NYSE IPO Guide

Managing risk Constructing a D&O liability program leading into an IPO is a dynamic process. The goal is to understand the choices and trade-offs and to achieve an optimal balance that properly reflects the values of the company and its directors and officers. For example, many companies purchase policies that protect both the company and the individual directors and officers for nonindemnifiable claims. This structure involves a shared limit of liability that protects the company and its directors and officers. If a very large claim is made against the company, it may exhaust the limits made available to individual directors and officers. One potential solution is to purchase additional limits of coverage dedicated solely to protect individual directors and officers. Alternatively, dedicated coverage may also be purchased solely for independent directors of the board, excluding nonindependent board members and officers. Selecting an appropriate level of limits is now more science than art. Peer benchmarking data is only one element to consider in choosing the right amount of insurance and retention. Analysis of a particular company’s susceptibility to securities class actions and projections of realistic settlement amounts can provide greater confidence in limit decisions. Turbulence affecting the financial condition of insurers several years ago has raised concerns regarding insurer stability, making the decisions on which insurers to partner with more challenging. An in-depth comparative analysis of an insurer’s creditworthiness and financial strength is a precursor to an assessment of the company’s counterparty risk. Just as important is the ongoing monitoring of the financial condition of the company’s partner insurers. One of the more complex and evolving areas of D&O coverage involves subsidiaries located outside the United States. It is important to understand the tax, regulatory and coverage issues associated with D&O exposures outside the United States to ascertain whether exposure exists. There are a number of solutions to address such exposure, depending on location and magnitude, some of which may impact the company’s choice of primary insurer. (c) Timing the D&O liability insurance purchase for an IPO A D&O policy for a newly public company generally becomes effective on the date the company’s registration statement covering the traded securities becomes effective. The process and timeline leading up to the commencement of the policy period differ depending on the situation and can be tailored to meet the specific needs of the company. The following is a suggested timeline for meeting key milestones in the process of obtaining D&O coverage. D&O strategy meeting: In the month leading into filing of Form S-1, it is recommended that the company meet with its insurance brokers and outside counsel, if needed, to strategize on D&O program design options, selection of carriers, coverage issues, limit analysis, timeline and cost. Being beneficiaries of D&O insurance, the entire board of directors or certain key members may need to be engaged. Filing of Form S-1: Once the company’s registration statement is filed, a submission can be made to the underwriters, which would include the draft Form S-1. Given the passage of the JOBS Act in 2012, a draft registration statement might be filed confidentially with the SEC. In such event, additional time and consideration should be given to obtaining nondisclosure agreements with insurers from which a company wishes to solicit a quote. The submission, combined with calls and/or face-to-face meetings with the underwriters, will allow the insurers to assess the company’s D&O risk profile. Timeline -45 to 0 days D&O strategy meeting 0 days Initial S-1 filed Information to underwriters Comments from SEC Meetings with underwriters: It is generally expected that senior representatives of the company will meet with the underwriters, either in person or by teleconference, before a premium quotation will be given for a D&O policy. It is an opportunity for the insurers to better understand the company’s financial and operating condition and its prospects and to speak directly with management about corporate governance issues and concerns. These meetings typically take place during the roadshow detailed in Chapter 3. Analysis: Once quotes have been submitted to the insurers, insurance advisors— sometimes working in concert with outside counsel—provide the company’s management and/or board with detailed comparative analysis to allow the company to ultimately make a number of decisions on the nature of its D&O program, including the appropriate structure, limits, retentions, coverage and insurers. Binding of insurance: Once decisions have been made by the company, insurance advisors will execute those decisions to build the D&O program and bind the insurers in time for the effectiveness of the registration statement. 8.5 Personal risk management Marsh An IPO will certainly have an impact on your professional life, but it will also have a considerable effect on your personal lifestyle. The complexity of a high net worth lifestyle requires a new way of thinking about risk and 30–40 days 35–50 days 45–60 days 60–75 days Initial feedback from client Amended S-1 filed Narrow field of underwriters Roadshow Underwriter calls and meetings Decide on program, limits, and structure IPO Bind public company D&O policy NYSE IPO Guide 93

Managing risk<br />

inadequately protects them. Outlined<br />

below are some specific circumstances<br />

where an individual officer or director may<br />

expect such protection.<br />

Derivative suit judgments or settlements:<br />

The ability of the company to indemnify<br />

its officers and directors for judgments or<br />

settlements resulting from a shareholder<br />

derivative action may be significantly<br />

limited or prohibited by statute in a<br />

company’s state of incorporation. For<br />

example, Delaware generally does not<br />

allow indemnification of settlements<br />

or judgments in an action brought by<br />

or on behalf of the company unless<br />

the court permits such action. In such<br />

circumstances, Side A coverage may<br />

apply as long as the conduct of individual<br />

directors and officers also complies with<br />

the limitations and exclusions of the<br />

insurance policy.<br />

Public policy prohibition against<br />

indemnification: Indemnification<br />

for claims related to registration of<br />

securities and antifraud provisions of<br />

the federal securities laws (and other<br />

federal statutes, such as the Racketeer<br />

Influenced and Corrupt Organizations Act<br />

and antitrust laws) may be precluded by<br />

public policy. The SEC’s view is that such<br />

indemnification is against public policy<br />

because it undermines the securities<br />

laws’ deterrent effect. However, the SEC<br />

does not regard the maintenance of D&O<br />

insurance as against public policy, even<br />

where the company pays the premium. As<br />

a result, it may be possible for insurance<br />

to respond to protect individual directors<br />

and officers in such circumstances where<br />

indemnification from the company is<br />

prohibited as a matter of public policy.<br />

Conduct not in “good faith” and<br />

“reasonable belief”: The company may<br />

indemnify a director or officer only if such<br />

person acted in good faith and in a manner<br />

that he or she reasonably believed to be<br />

in, or not opposed to, the best interests of<br />

the company. As a result, acts that do not<br />

satisfy the “good faith” and “reasonable<br />

belief” standard may not be indemnified<br />

by the company. In such circumstances,<br />

claims made against an individual director<br />

or officer may be insurable so long as the<br />

conduct of such individual also complies<br />

with the limitations and exclusions of the<br />

insurance policy.<br />

Refusal by board to indemnify: If the<br />

board or other authorized designee<br />

either declines in writing to indemnify<br />

an individual or fails to make or initiate<br />

a determination to indemnify an<br />

individual, insurance may respond to<br />

protect individual directors and officers,<br />

but it may be subject to a retention or<br />

deductible depending on the structure of<br />

the program.<br />

To avoid a circumstance where an<br />

individual insured might be personally<br />

responsible to pay a retention, many<br />

public companies today purchase a<br />

variation of Side A insurance often<br />

referred to as Side A DIC (the “DIC”<br />

refers to the “difference in conditions”<br />

provisions that are contained in this<br />

type of insurance policy). Side A DIC<br />

insurance provides broader coverage and<br />

is often purchased in addition to and in<br />

excess of the traditional D&O (Sides A,<br />

B and C) insurance described above. In a<br />

circumstance where the board or other<br />

authorized designee declines to indemnify<br />

an individual as described above, Side A<br />

DIC insurance could be called upon to<br />

provide directors and officers coverage<br />

at the primary level of the program (no<br />

retention).<br />

Near insolvency: Should the company<br />

approach insolvency, it will approach<br />

the “zone of insolvency,” where officers<br />

and directors may be deemed to owe<br />

certain fiduciary duties to creditors of the<br />

company. Although not yet insolvent, the<br />

company might choose not to indemnify a<br />

particular director or officer for fear that<br />

such act may be a breach of fiduciary duty<br />

owed to creditors of the company or may<br />

be the subject of an order by a bankruptcy<br />

trustee to return those proceeds. Insurance<br />

may respond if limits of the policy are not<br />

otherwise eroded.<br />

Actual insolvency or bankruptcy: The<br />

company either may be insolvent or, in<br />

the context of U.S. bankruptcy laws, may<br />

be unable or unwilling to indemnify an<br />

officer or director if the bankruptcy trustee<br />

determines that such indemnification is<br />

either unwarranted or improper. Moreover,<br />

assuming that such indemnification of<br />

an officer or director was warranted and<br />

proper, the proceeds of the policy might be<br />

deemed an asset of the “estate” and subject<br />

to an automatic stay. The obligation to<br />

indemnify may be deemed an unsecured<br />

obligation, placing the affected officer’s or<br />

director’s interest behind the interests of<br />

secured creditors and on par with other<br />

unsecured creditors awaiting payment or<br />

settlement.<br />

If there is some risk that the company<br />

may avail itself of the protection of U.S.<br />

bankruptcy laws, it may be useful to<br />

seek an explanation from the company’s<br />

insurance advisor and counsel as to how<br />

the company’s D&O insurance policy may<br />

respond to a number of potential issues.<br />

Key issues to understand would include<br />

identifying any issues related to:<br />

• how limits in the policy are either<br />

allocated or prioritized to coverage<br />

other than coverage of claims made<br />

against a director’s or officer’s personal<br />

assets;<br />

• whether the design of the company’s<br />

D&O insurance program is such that<br />

directors or officers will not be subject<br />

to a retention or deductible if the<br />

company is permitted to but fails to<br />

indemnify such an individual; and<br />

• what—if any—language exists in the<br />

policy to waive an automatic stay as<br />

regards the company’s policy.<br />

Choosing a D&O policy structure, limits,<br />

retention and insurers: The company<br />

should consider several questions before<br />

selecting the limits and structure of its<br />

D&O policy, including the following:<br />

• How susceptible is the company to<br />

a class action lawsuit or government<br />

enforcement action?<br />

• If the company suffers a class action<br />

lawsuit, what might it cost to defend<br />

and settle?<br />

• What limits, structures and retentions<br />

do the company’s peers purchase?<br />

• How can the balance between coverage,<br />

limit, retention and price be optimized?<br />

• What is the overall financial stability of<br />

each insurer on the program?<br />

• How can the program most costeffectively<br />

address exposure for foreign<br />

directors and officers?<br />

92 NYSE IPO Guide

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!